FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
|
Anand Rathi, Angel One, Capital Market, Chittorgarh.com Team, Kotak Securities, Mehta Equities, Narnolia Financial Advisors Ltd (NFAL), Rudra Shares & Stock Brokers Ltd and Ventura Securities Limited have given "Apply" recommendation to Rossari Biotech IPO. Choice Equity Broking Pvt Ltd, Dilip Davda and SMC Global have given "May Apply" recommendation to Rossari Biotech IPO. Axis Capital, HDFC Securities Limited and Motilal Oswal have "Not Rated" the IPO.
Review By | Apply | May Apply | Neutral | Avoid | Not Rated |
---|---|---|---|---|---|
Count | 9 | 3 | 0 | 0 | 3 |
% | 60.00 | 20.00 | 0.00 | 0.00 | 20.00 |
Reviewer | Recommendation | Past Reviews |
---|---|---|
Anand Rathi | Apply | |
Angel One | Apply | |
Axis Capital | Not Rated | |
Capital Market | Apply | |
Chittorgarh.com Team | Apply | |
Choice Equity Broking Pvt Ltd | May Apply | |
Dilip Davda | May Apply | |
HDFC Securities Limited | Not Rated | |
Kotak Securities | Apply | |
Motilal Oswal | Not Rated | |
Mehta Equities | Apply | |
Narnolia Financial Advisors Ltd (NFAL) | Apply | |
Rudra Shares & Stock Brokers Ltd | Apply | |
SMC Global | May Apply | |
Ventura Securities Limited | Apply |
The Captial Market (CapitalMarket.com) rating for Rossari Biotech IPO is 48. Their analysis recommends May subscribe for the IPO.
Reviewer | Rating Score | Rating |
---|---|---|
Capital Market | 48 | May subscribe |
[Dilip Davda] On the current parameters, the issue appears fully priced. However, considering bright prospects going forward with more than double installed capacity and rising patronage by top clients with long term relations, investors may consider investment for long term rewards. Read detail review...
Post Recommendation Manage Recommendations
Note:
Rs 0 Account Opening Fee
Free Eq Delivery & MF
Flat ₹20 Per Trade in F&O
FREE Intraday Trading (Eq, F&O)
Flat ₹20 Per Trade in F&O
|